Hjem › Crohns sykdom › Minnesota
Kliniske studier for Crohns sykdom i Minnesota
11 studier for Crohns sykdom søker deltakere på steder i Minnesota.
Byer i Minnesota
Offisiell studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Mayo Clinic in Rochester, Minnesota ( Site 5024), Rochester
RekruttererFase 3
Alder 16 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06430801Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Mayo Clinic-Rochester /ID# 265550, Rochester
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06548542A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Mayo Clinic 1, Rochester
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07196722A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- MNGI Digestive Health, P. A. /ID# 255366, Minneapolis
RekruttererFase 3
Alder 2 til 17 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT05995353Standardized Microbiota Transplant Therapy in Crohn's Disease
- University of Minnesota, Minneapolis
RekruttererFase 2
Alder 18 til 89 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06631586Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- MNGI Digestive Health, P. A. /ID# 262204, Minneapolis
RekruttererFase 3
Alder 2 til 17 · Alle kjønn · Oppdatert 24. jun. 2026 · NCT06332534A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- MNGI Digestive Health, PA, Minneapolis
- Mayo Clinic - PIN, Rochester
RekruttererFase 3
Alder 2 til 17 · Alle kjønn · Oppdatert 5. mai 2026 · NCT0477932068Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
- Mayo Clinic, Rochester
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 9. feb. 2026 · NCT07273188Treatment of Moderate to Severe Refractory Crohn's Disease
- Mayo Clinic Rochester, Rochester
RekruttererFase 1/2
Alder 18 til 65 · Alle kjønn · Oppdatert 10. des. 2025 · NCT06721962Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
- Mayo Clinic- Rochester, Rochester
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 12. nov. 2025 · NCT06670638Helmsley 3.0: Abbreviated MRE
- Mayo Clinic, Rochester
RekruttererObservasjonsstudie
Alder 10 og eldre · Alle kjønn · Oppdatert 27. okt. 2025 · NCT06533228Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.